由于低于最佳的抗凝血,在伴心膜生物假体替换后早期的大规模左心室血栓形成:一个病例报告
Wanli Liu1, Zhongkui Li1, Chao Feng1
1Department of Cardiovascular Medicine, Guizhou Provincial People's Hospital, Guiyang, CHN.
Cureus
|October 20, 2025
概括
生物假肢门置换后的一种罕见的大规模左心房血栓,通过强化华法林治疗得到解决. 严格的国际正常化比率 (INR) 监测对于高风险患者在手术后至关重要.
科学领域:
- 心血管外科心血管外科
- 心脏外科手术 心脏外科手术
- 血栓形成研究研究
背景情况:
- 胸前血栓是 mitra 置换后不常见的并发症.
- 早期的术后血栓形成存在重大风险.
研究的目的:
- 为了报告一个罕见的严重左心房血栓在生物假体中心替换后的罕见病例.
- 强调警抗凝管理和监测的重要性.
主要方法:
- 一名61岁的女性患者接受了生物假体关节置换.
- 大型左心房血栓的诊断是在两个月后的随访中进行的,并进行了次治疗的INR.
- 治疗涉及加强华法林治疗和与纳德罗巴林桥接.
主要成果:
- 左心房血栓的尺寸为79 × 55 × 45毫米.
- 强化抗凝治疗导致血栓在三周内减少.
- 血栓在治疗后三个月内完全消失.
- 通过心声回声学证实了生物假体门的满意功能.
结论:
- 华法林治疗可以有效地治疗左心房血栓在中心替换后的治疗.
- 严格的国际规范化比率 (INR) 监测对于高风险患者至关重要.
- 及时的抗凝调整是成功解决血栓和患者康复的关键.
更多相关视频
相关概念视频
Mitral Stenosis I: Introduction
453
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
453
Mitral Stenosis III: Medical Management
245
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
245
Mitral Stenosis II: Clinical features and Diagnostic Tests
215
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215
Mitral Valve Prolapse I: Introduction
374
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
374
Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
Mitral Valve Prolapse II: Assessment and Management
411
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
411


